Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor ...

Medicaid expansion was associated with a slower decrease in receipt of guideline-concordant treatment, reduced delays in treatment initiation, and improved 2-year survival, according to researchers.

News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...

Mabel Mardones, MD, Rocky Mountain Cancer Centers, discusses the future of HR+/HER2– breast cancer treatment, focusing on the importance of biomarkers and the potential of SIRDs to improve patient ...

Source: Getty Images Phase 2 trial results support further development of camizestrant for the treatment of estrogen receptor-positive, HER2-negative breast cancer, according to researchers. The ...

Recess Therapy/Youtube While Rihanna revealed that ... Rihanna Is a Relatable Mom as She Prepares for Halloween with Her 2 Sons: 'It Ran Up on Me Really Quickly ...

Cite this: The Role of Hormonal Therapy in the Management of Hormonal-Receptor-Positive Breast Cancer With Co-Expression of HER2 - Medscape - Sep 01, 2008. The article is based primarily on a ...

The goal was to present recommendations for treatment strategies and sequencing for patients with oestrogen-receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-), advanced ...

HER2 status, along with a tumor's hormone status and other factors, helps determine the prognosis and treatment options for breast cancer. Breast cancer is not a single disease, and researchers now ...